Stock Market News for April 23, 2026
930 news published.
Technology, AI infrastructure and data center demand
Applied Digital (APLD) announced a new U.S.-based high investment-grade hyperscaler tenant at its Delta Forge 1 430 MW AI factory campus, reinforcing hyperscaler leasing as a valuation anchor for data centers; see the announcement.
VivoPower (VIVO) launched lease bidding after strong interest from AI operators for a 41.5 MW Norway data center, signaling rising competition for edge and regional capacity in Europe; read the notice.
Digital Realty (DLR) reported Q1 2026 results today; investors will watch occupancy, leasing spreads and development pipelines for signs that AI-driven leasing sustains pricing power—full details in the report.
Rexford Industrial (REXR) announced first-quarter 2026 financial results, offering fresh signals on industrial leasing momentum in the Sun Belt and implications for logistics capacity that often complements hyperscaler and edge demand; see the release.
Semiconductors, AI compute and enabling tech
Intel (INTC) reported Q1 2026 financial results with updated revenue, margin and capex guidance that investors will parse for the datacenter cycle and foundry spending intentions; read the release.
STMicroelectronics (STM) provided Q1 2026 financials that shed light on auto and industrial demand and guidance for capex and inventory normalization—see the report.
Quantum Computing Inc. (QUBT) unveiled NeuraWave, a photonic platform for real-time AI inference at the edge—a potential alternative to GPU-dominant stacks if pilots scale.
Ad measurement, retail AI and ad tech automation
DoubleVerify (DV) became the first measurement provider to earn MRC accreditation for TikTok video viewability reporting, a win that could bolster advertiser confidence and media budgets into verified social-video channels.
Taboola (TBLA) launched Realize+, an agentic AI system that translates advertiser goals into outcomes and integrates with Claude skills—watch early ROI signals for campaign automation.
Healthcare and biotech: approvals, pricing and commercial access
Regeneron (REGN) updated its FDA approval news with a U.S. government agreement to help lower drug costs and a commitment to provide its gene therapy for genetic hearing loss at no cost in the U.S.; this blends a regulatory milestone with price-and-access implications—details in the announcement.
AbbVie (ABBV) provided an update on the TrenibotE Biologics License Application in the U.S., a key regulatory checkpoint for a late-stage neurology asset that could affect AbbVie’s growth profile; read the notice.
GE HealthCare (GEHC) announced the first patient dosed in the Phase 2/3 LUMINA trial for a manganese-based MRI contrast agent under FDA fast track—an imaging milestone with potential commercial upside if the program succeeds; see the update.
Real estate and REITs
Gaming and Leisure Properties (GLPI) reported record Q1 2026 results and raised full-year guidance, a notable cash-flow and buyback tailwind in the REIT space; read the report.
DigitalBridge (DBRG) stockholders approved SoftBank Group Corp.’s acquisition, clearing a major vote and moving the deal closer to close—such buyouts can shift private-market valuations for infrastructure assets; see the vote notice.
Energy, materials and metals: earnings and regulatory milestones
Newmont (NEM) generated record quarterly earnings and free cash flow and announced an increased share repurchase authorization—strong cash generation and an expanded buyback can support a sector re-rating; read the report.
Freeport-McMoRan (FCX) posted Q1 results; investors will parse copper production and cost trends given sensitivity to global industrial demand—see the update.
Duke Energy (DUK) won approval for the Robinson Nuclear Plant to continue operating until 2050 from the U.S. Nuclear Regulatory Commission, extending generation visibility and long-term capacity planning for the utility sector; read the ruling.
Defense and aerospace moves reshape contractor outlooks
L3Harris (LHX) closed a $1 billion Department of War investment into its missile solutions business, reinforcing government-funded modernization tailwinds; see the announcement.
Leidos (LDOS) received a $617 million U.S. Army award for air-defense launchers, underlining multi-year defense spending themes; read the contract notice.
Transportation and industrials: rails, chemicals and capex cues
Union Pacific (UNP) reported Q1 2026 results that give fresh signals on freight volumes, pricing power and capital allocation—key inputs for industrial cyclicality; view the earnings report.
Financials and markets: exchanges, guidance beats and derivatives
Nasdaq (NDAQ) posted strong Q1 results with double-digit net revenue growth across divisions, highlighting exchange and data-driven resilience; full report.
Sallie Mae (SLM) reported Q1 2026 results and raised full-year diluted EPS guidance, a constructive sign for consumer credit dynamics and investor sentiment in the credit-card and student-loan-adjacent space; see the release.
USCB Financial Holdings (USCB) delivered a record quarter with $0.51 diluted EPS, up 33% year-over-year, highlighting community-bank profitability and improving credit metrics; read the results.
StoneX (SNEX) partnered with Expana to roll out new OTC dairy derivatives, expanding commodity-derivatives offerings that can attract hedging flows; read the release.
Banks and regional lenders: earnings and credit trends
Dime Community Bancshares (DCBG) reported a 10% Q/Q increase and 67% Y/Y rise in EPS, a standout regional-bank print that may draw investor attention on margin expansion; see the release.
- Hilltop Holdings (HTH) announced Q1 2026 financial results today; regional-bank investors will parse net interest margin trends and credit reserve moves for signs of durable earnings power—see the report.
- Blue Ridge Bankshares (BRBS) posted first-quarter results that add to the tape of regional-bank earnings prints; watch deposit trends and expense discipline in the release.
- Primis Financial (FRST) reported strong Q1 results, another data point on community-bank profitability and loan growth that investors use to gauge local credit conditions; read the results.
Corporate actions, listings and capital moves
Lakewood-Amedex Biotherapeutics (LABT) completed a direct listing on Nasdaq under LABT, a liquidity mechanism that changes early price discovery dynamics versus a traditional IPO; see the filing.
Genius Group (GNS) identified 30.1 million shares to be retired and removed from the public float—share-retirements can support per-share metrics if underlying value holds; read the filing.
OIO Group (OIO) completed its De Tomaso business combination, establishing a new control and strategic platform—transactions like this alter ownership and can reset corporate strategy; see the announcement.
Selected corporate moves and partnerships
- Cognizant (CTSH) — AI Lab earned three U.S. patents, bringing totals to 65 U.S. and 88 international, reinforcing IP depth for enterprise AI services; see the release.
- Accenture (ACN) invested in Iridius to accelerate compliance-first AI adoption in life sciences—an angle that could speed regulated enterprise deployments; read the announcement.
Personnel and governance
SES AI (SES) reported Q1 2026 financial results and announced a CFO transition; management changes at AI-infra providers and fresh financials are key for investor views on execution and capital allocation—see the results and the CFO announcement.
What to watch next
Focus on hyperscaler lease announcements, chipmakers’ capex guidance, and earnings guidance moves that directly affect valuation. In financials, watch guidance raises and strong regional-bank prints for shifting credit sentiment. For REITs, GLPI’s upgraded outlook and Rexford’s industrial read provide cues on cash flow and buyback potential. Finally, track regulatory milestones such as the Robinson nuclear approval and management changes at AI-infrastructure firms like SES AI (SES), which can signal near-term strategy shifts and capital priorities.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement